The news section covers important news related to MedicWave activities.
2010-04-19 - 2010-04-21
MedicWave attended the ProteoMMX conference in Chester, UK. The conference covered topics related to Label-free and label-mediated quantification, informatics for quantification, data standards for quantitative proteomics data, quantification of post-translational modifications, in vitro labels and metabolic labeling, including SILAC and dynamic SILAC.
2010-03-24 - 2010-03-26
MedicWave attended the 2nd Conference of Polish Mass Spectrometry Society in Poznan, Poland.
2010-03-08
MedicWave's new product, MBS™ 4.0, was released today. MBS™ will be sent out to the people who, during the DGMS Conference in Halle (Germany), requested to receive a 1-month free trial of the software. Send an e-mail to MedicWave to request a free trial version of MBS™.
2010-03-07 - 2010-03-10
MedicWave attended the German MS conference in Halle, Germany. During the conference (on Monday), MedicWave held a lunch seminar about MBS™ and it's new module LEQuant. 50 people attended the lunch seminar, including Professor Dr. J. Grotemeyer, Professor H. Schlüter, Professor O. Kohlbacher, Professor B. Spengler and Professor P. Roepstorff.
2010-03-01 - 2010-03-02
MedicWave attended the 3rd OpenMS User Meeting in Dortmund, Germany. During the meeting Professor Knut Reinert and Professor Oliver Kohlbacher, the developers of OpenMS, presented the capabilities of OpenMS and discussed future directions in mass spectrometry.
2010-01-21 - 2010-01-22
MedicWave attended the Danish mass spectrometry conference. This year the meeting was held in the city Svendborg with a two-day session covering a broad spectrum of MS topics including keynote lectures.
2009-10-14 - 2009-10-16
The focus of PathProt II will be on toxicity and safety problems in what concerns their possible assessment via pathways and networks. Pathway Analysis is a window of opportunity to address this class of problems, using existing and experimental (Proteomic) biological information and computational methods to focus on the critical parts of complex networks. A safety issue around drug candidates is the prime reason for industrial pharma industry's limited success in clinical trials. Solving this problem will remove a major obstacle in producing novel efficient medicines. While this may sound too ambitious for the moment, it is very useful to start thinking about screening using in-silico methodologies such as PA. In a very much similar way, food industries are recognizing the value of reducing the complexity and cost of screening, reducing the actual testing to the relevant ones only, and that is something tha PA can help with, narrowing the scope of the experimentation. Finally, as controls become tighter for characterizing chemical compounds in terms of toxicity, there is plenty of room for using PA and other in-silico techniques to lower the complexity and cost of testing, reducing animal experimentation etc. To be specific, the need is arising to reduce the size and complexity of toxicologial tests to industrially produced chemical compounds, reducing financial costs and animal experimentation.The recent introduction of the REACH regulation in Europe will be struggling with such problem, as the registration in 2008 of over 140,000 substances by over 65,000 companies has exceeded the expectations in 300 to 400% (Nature, Vol 460, 27 Aug 2009, pp 1080-1081 - OPINION). There will be no solution but to screen and reduce in size and complexity. For sure, in-silico results will be fundamental in this concern.
PathProt-II was the second workshop with focus on PA, and it was held in Portugal. PathProt is a forum that will bring together people from different areas, including Medicine, Molecular Biology, Proteomics, Bioinformatics and Instrumentation, and initiate the collective thinking process towards the common goal of shaping the emerging scientific discipline of Analytical Pathway Biology. PathProt-II was organized by: Roman Zubarev, Pedro Fernandes, and Alexander Kel.
2009-10-07
MedicWave held an extra General Meeting. The General Meeting decided to split all MedicWave shares by ten.
2009-09-21
MedicWave's new product, MBS™ 3.0, was released today. MBS™ will be sent out to the people who, during the 18th International Mass Spectrometry Conference in Bremen (Germany), requested to receive a 1-month free trial of the software. Send an e-mail to MedicWave to request a free trial version of MBS™.
2009-08-30 - 2009-09-04
MedicWave attended the 18th International Mass Spectrometry Conference (IMSC) in Bremen, Germany. More than 2500 people attended the conference during a week's time. Many renowned research scientists graced the conference with their presence, i.e. Professor Matthias Mann, Professor Wolf-Dieter Lehmann, Professor Hartmut Schlüter, Professor Michael Karas, Professor Bernhard Spengler and Professor Michael Przybylski. This conference is held every 3rd years and has been done so since the 1st conference in London in 1958.
Click here to view an interview with Professor Jürgen Grotemeyer, a renowned expert in Mass Spectrometry and the Chairman of IMSC 2009.
MedicWave AB
Stålverksgatan 1
SE-302 45 HALMSTAD
SWEDEN
Org. nr: 556690-4677
VAT: SE556690467701
Telephone: +46 (0)35 133 600
(Monday - Friday, 10 am - 6 pm GMT+1)
E-mail: info@medicwave.com